sur ABIVAX (EPA:ABVX)
ABIVAX: Statement of Share Capital and Voting Rights as of July 31, 2026
ABIVAX, a biotechnology company listed on Euronext Paris, has published its share capital and voting rights figures as of July 31, 2026. ABIVAX's share capital amounts to €872,537.97, divided into 87,253,797 shares. These shares carry a total of 88,512,554 theoretical and exercisable voting rights.
Theoretical voting rights include all shares, including those without voting rights, and serve as the basis for calculating threshold crossings in accordance with AMF regulations. Executable voting rights, on the other hand, exclude these shares without voting rights.
This information falls within the legal framework governing corporate transparency towards financial market participants.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ABIVAX